Clinical evaluation of Candida albicans enolase 1 as a novel biomarker for vulvovaginal candidiasis: a pilot study demonstrating rule-out capability

Hanbing Meng, Huimin Xing, Qingqing Sun, Fang Li, Zhengxin He

Open source

DOI
10.1186/s12905-026-04660-3
Published
2026-07-06
Container
BMC Women's Health
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12905-026-04660-3,
  title = {Clinical evaluation of Candida albicans enolase 1 as a novel biomarker for vulvovaginal candidiasis: a pilot study demonstrating rule-out capability},
  author = {Hanbing Meng and Huimin Xing and Qingqing Sun and Fang Li and Zhengxin He},
  year = {2026},
  journal = {BMC Women's Health},
  doi = {10.1186/s12905-026-04660-3},
  url = {https://doi.org/10.1186/s12905-026-04660-3}
}

RIS

TY  - JOUR
TI  - Clinical evaluation of Candida albicans enolase 1 as a novel biomarker for vulvovaginal candidiasis: a pilot study demonstrating rule-out capability
AU  - Hanbing Meng
AU  - Huimin Xing
AU  - Qingqing Sun
AU  - Fang Li
AU  - Zhengxin He
PY  - 2026
JO  - BMC Women's Health
DO  - 10.1186/s12905-026-04660-3
UR  - https://doi.org/10.1186/s12905-026-04660-3
ER  - 

APA

Meng, H., Xing, H., Sun, Q., Li, F., & He, Z. (2026). Clinical evaluation of Candida albicans enolase 1 as a novel biomarker for vulvovaginal candidiasis: a pilot study demonstrating rule-out capability. BMC Women's Health. https://doi.org/10.1186/s12905-026-04660-3

Source records